Industry Research Reports
Home > Reports > Medical Devices & Consumables > Chromosomal Microarray- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Chromosomal Microarray- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 106 Pages
Report ld: 3483121
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Chromosomal Microarray Market Size(US$)
CAGR 2025-2031
8.8%
Market Size,2031
USD 3,149
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,898 million
Market Forecast in 2031(Value)
US$ 3,149 million
CAGR
8.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Chromosomal Microarray was estimated to be worth US$ 1759 million in 2024 and is forecast to a readjusted size of US$ 3149 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
The global chromosomal microarray market is a growing segment of the molecular diagnostics industry that focuses on the use of chromosomal microarray analysis (CMA) technology for genetic testing. CMA is a high-resolution technique used to detect chromosomal abnormalities and copy number variations (CNVs) in an individual’s DNA.
Here are some key insights into the global chromosomal microarray market:
Market Size and Growth: The global chromosomal microarray market has witnessed significant growth in recent years and is expected to continue expanding. Factors driving market growth include increasing awareness and adoption of CMA as a diagnostic tool, advancements in genomic technologies, and a growing prevalence of genetic disorders and developmental disabilities.
Application Areas: Chromosomal microarray analysis is used in various clinical applications, including prenatal testing, postnatal testing, cancer diagnostics, and research applications. In the prenatal setting, CMA is commonly used for detecting chromosomal abnormalities in fetuses, including common conditions such as Down syndrome. In postnatal testing, CMA helps identify genetic causes of developmental delays, intellectual disabilities, and autism spectrum disorders, among others.
Technological Advancements: The chromosomal microarray market is witnessing continuous technological advancements in terms of higher resolution arrays, improved detection sensitivity, and enhanced analysis software. These advancements enable more accurate and comprehensive detection of genomic abnormalities, driving the market’s growth.
Market Players: The global chromosomal microarray market is highly competitive, with several established players and emerging companies. Some of the key players in the market include Agilent Technologies Inc., Illumina Inc., Oxford Gene Technology Ltd., PerkinElmer Inc., Affymetrix Inc. (Thermo Fisher Scientific), and Applied Microarrays Inc., among others. These companies are investing in research and development to improve their CMA offerings and expand their market presence.
Regional Analysis: North America accounts for a significant share of the global chromosomal microarray market, attributed to the presence of key market players, advanced healthcare infrastructure, and high awareness and adoption rates of genetic testing. Europe and the Asia-Pacific region are also witnessing significant growth in the field, driven by expanding healthcare infrastructure, increasing focus on personalized medicine, and rising demand for genetic testing services.
Regulatory Standards: Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established guidelines and standards for the use of CMA in clinical diagnostics. Compliance with these regulations and obtaining necessary approvals or clearances is essential for market entry and commercialization of CMA products.
Collaborations and Partnerships: Companies operating in the chromosomal microarray market often engage in collaborations, partnerships, and strategic alliances to enhance their product offerings, expand their geographic presence, and leverage complementary expertise. These collaborations aim to accelerate innovation and provide comprehensive genetic testing solutions to healthcare providers worldwide.
In summary, the global chromosomal microarray market is experiencing steady growth driven by advancements in genomic technologies, increasing prevalence of genetic disorders, and growing adoption of genetic testing for personalized medicine. The market is characterized by the presence of established players and continuous investments in research and development. As awareness and demand for chromosomal microarray analysis increase, the market is expected to expand further in the coming years.The global chromosomal microarray market is a growing segment of the molecular diagnostics industry that focuses on the use of chromosomal microarray analysis (CMA) technology for genetic testing. CMA is a high-resolution technique used to detect chromosomal abnormalities and copy number variations (CNVs) in an individual’s DNA.
Here are some key insights into the global chromosomal microarray market:
Market Size and Growth: The global chromosomal microarray market has witnessed significant growth in recent years and is expected to continue expanding. Factors driving market growth include increasing awareness and adoption of CMA as a diagnostic tool, advancements in genomic technologies, and a growing prevalence of genetic disorders and developmental disabilities.
Application Areas: Chromosomal microarray analysis is used in various clinical applications, including prenatal testing, postnatal testing, cancer diagnostics, and research applications. In the prenatal setting, CMA is commonly used for detecting chromosomal abnormalities in fetuses, including common conditions such as Down syndrome. In postnatal testing, CMA helps identify genetic causes of developmental delays, intellectual disabilities, and autism spectrum disorders, among others.
Technological Advancements: The chromosomal microarray market is witnessing continuous technological advancements in terms of higher resolution arrays, improved detection sensitivity, and enhanced analysis software. These advancements enable more accurate and comprehensive detection of genomic abnormalities, driving the market’s growth.
Market Players: The global chromosomal microarray market is highly competitive, with several established players and emerging companies. Some of the key players in the market include Agilent Technologies Inc., Illumina Inc., Oxford Gene Technology Ltd., PerkinElmer Inc., Affymetrix Inc. (Thermo Fisher Scientific), and Applied Microarrays Inc., among others. These companies are investing in research and development to improve their CMA offerings and expand their market presence.
Regional Analysis: North America accounts for a significant share of the global chromosomal microarray market, attributed to the presence of key market players, advanced healthcare infrastructure, and high awareness and adoption rates of genetic testing. Europe and the Asia-Pacific region are also witnessing significant growth in the field, driven by expanding healthcare infrastructure, increasing focus on personalized medicine, and rising demand for genetic testing services.
Regulatory Standards: Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established guidelines and standards for the use of CMA in clinical diagnostics. Compliance with these regulations and obtaining necessary approvals or clearances is essential for market entry and commercialization of CMA products.
Collaborations and Partnerships: Companies operating in the chromosomal microarray market often engage in collaborations, partnerships, and strategic alliances to enhance their product offerings, expand their geographic presence, and leverage complementary expertise. These collaborations aim to accelerate innovation and provide comprehensive genetic testing solutions to healthcare providers worldwide.
In summary, the global chromosomal microarray market is experiencing steady growth driven by advancements in genomic technologies, increasing prevalence of genetic disorders, and growing adoption of genetic testing for personalized medicine. The market is characterized by the presence of established players and continuous investments in research and development. As awareness and demand for chromosomal microarray analysis increase, the market is expected to expand further in the coming years.
This report aims to provide a comprehensive presentation of the global market for Chromosomal Microarray, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Chromosomal Microarray by region & country, by Type, and by Application.
The Chromosomal Microarray market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chromosomal Microarray.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories
- MedGenome
- Scott Minifab
- Agilent Technologies Inc.
- Perkin Elmer Inc.
- Illumina Inc.
- Microarrays Inc.
- Merck KGaA
- Arrayit Corporation
- GE Healthcare
- Molecular Devices LLC
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Xon Array
- 750K Array
- Optima Array
- Others
Segment by Application
- Autism
- Angelman Syndrome
- Williams Syndrome
- DiGeorge Syndrome
- Prader-Willi Syndrome
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chromosomal Microarray company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Chromosomal Microarray in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Chromosomal Microarray in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Chromosomal Microarray Product Introduction
1.2 Global Chromosomal Microarray Market Size Forecast (2020-2031)
1.3 Chromosomal Microarray Market Trends & Drivers
1.3.1 Chromosomal Microarray Industry Trends
1.3.2 Chromosomal Microarray Market Drivers & Opportunity
1.3.3 Chromosomal Microarray Market Challenges
1.3.4 Chromosomal Microarray Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chromosomal Microarray Players Revenue Ranking (2024)
2.2 Global Chromosomal Microarray Revenue by Company (2020-2025)
2.3 Key Companies Chromosomal Microarray Manufacturing Base Distribution and Headquarters
2.4 Key Companies Chromosomal Microarray Product Offered
2.5 Key Companies Time to Begin Mass Production of Chromosomal Microarray
2.6 Chromosomal Microarray Market Competitive Analysis
2.6.1 Chromosomal Microarray Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Chromosomal Microarray Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chromosomal Microarray as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Xon Array
3.1.2 750K Array
3.1.3 Optima Array
3.1.4 Others
3.2 Global Chromosomal Microarray Sales Value by Type
3.2.1 Global Chromosomal Microarray Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Chromosomal Microarray Sales Value, by Type (2020-2031)
3.2.3 Global Chromosomal Microarray Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Autism
4.1.2 Angelman Syndrome
4.1.3 Williams Syndrome
4.1.4 DiGeorge Syndrome
4.1.5 Prader-Willi Syndrome
4.1.6 Others
4.2 Global Chromosomal Microarray Sales Value by Application
4.2.1 Global Chromosomal Microarray Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Chromosomal Microarray Sales Value, by Application (2020-2031)
4.2.3 Global Chromosomal Microarray Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Chromosomal Microarray Sales Value by Region
5.1.1 Global Chromosomal Microarray Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Chromosomal Microarray Sales Value by Region (2020-2025)
5.1.3 Global Chromosomal Microarray Sales Value by Region (2026-2031)
5.1.4 Global Chromosomal Microarray Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Chromosomal Microarray Sales Value, 2020-2031
5.2.2 North America Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Chromosomal Microarray Sales Value, 2020-2031
5.3.2 Europe Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Chromosomal Microarray Sales Value, 2020-2031
5.4.2 Asia Pacific Chromosomal Microarray Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Chromosomal Microarray Sales Value, 2020-2031
5.5.2 South America Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Chromosomal Microarray Sales Value, 2020-2031
5.6.2 Middle East & Africa Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chromosomal Microarray Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Chromosomal Microarray Sales Value, 2020-2031
6.3 United States
6.3.1 United States Chromosomal Microarray Sales Value, 2020-2031
6.3.2 United States Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Chromosomal Microarray Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Chromosomal Microarray Sales Value, 2020-2031
6.4.2 Europe Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Chromosomal Microarray Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Chromosomal Microarray Sales Value, 2020-2031
6.5.2 China Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
6.5.3 China Chromosomal Microarray Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Chromosomal Microarray Sales Value, 2020-2031
6.6.2 Japan Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Chromosomal Microarray Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Chromosomal Microarray Sales Value, 2020-2031
6.7.2 South Korea Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Chromosomal Microarray Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Chromosomal Microarray Sales Value, 2020-2031
6.8.2 Southeast Asia Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Chromosomal Microarray Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Chromosomal Microarray Sales Value, 2020-2031
6.9.2 India Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
6.9.3 India Chromosomal Microarray Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Profile
7.1.2 Thermo Fisher Scientific Inc. Main Business
7.1.3 Thermo Fisher Scientific Inc. Chromosomal Microarray Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Inc. Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.1.5 Thermo Fisher Scientific Inc. Recent Developments
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Profile
7.2.2 Bio-Rad Laboratories Main Business
7.2.3 Bio-Rad Laboratories Chromosomal Microarray Products, Services and Solutions
7.2.4 Bio-Rad Laboratories Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.2.5 Bio-Rad Laboratories Recent Developments
7.3 MedGenome
7.3.1 MedGenome Profile
7.3.2 MedGenome Main Business
7.3.3 MedGenome Chromosomal Microarray Products, Services and Solutions
7.3.4 MedGenome Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.3.5 MedGenome Recent Developments
7.4 Scott Minifab
7.4.1 Scott Minifab Profile
7.4.2 Scott Minifab Main Business
7.4.3 Scott Minifab Chromosomal Microarray Products, Services and Solutions
7.4.4 Scott Minifab Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.4.5 Scott Minifab Recent Developments
7.5 Agilent Technologies Inc.
7.5.1 Agilent Technologies Inc. Profile
7.5.2 Agilent Technologies Inc. Main Business
7.5.3 Agilent Technologies Inc. Chromosomal Microarray Products, Services and Solutions
7.5.4 Agilent Technologies Inc. Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.5.5 Agilent Technologies Inc. Recent Developments
7.6 Perkin Elmer Inc.
7.6.1 Perkin Elmer Inc. Profile
7.6.2 Perkin Elmer Inc. Main Business
7.6.3 Perkin Elmer Inc. Chromosomal Microarray Products, Services and Solutions
7.6.4 Perkin Elmer Inc. Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.6.5 Perkin Elmer Inc. Recent Developments
7.7 Illumina Inc.
7.7.1 Illumina Inc. Profile
7.7.2 Illumina Inc. Main Business
7.7.3 Illumina Inc. Chromosomal Microarray Products, Services and Solutions
7.7.4 Illumina Inc. Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.7.5 Illumina Inc. Recent Developments
7.8 Microarrays Inc.
7.8.1 Microarrays Inc. Profile
7.8.2 Microarrays Inc. Main Business
7.8.3 Microarrays Inc. Chromosomal Microarray Products, Services and Solutions
7.8.4 Microarrays Inc. Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.8.5 Microarrays Inc. Recent Developments
7.9 Merck KGaA
7.9.1 Merck KGaA Profile
7.9.2 Merck KGaA Main Business
7.9.3 Merck KGaA Chromosomal Microarray Products, Services and Solutions
7.9.4 Merck KGaA Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.9.5 Merck KGaA Recent Developments
7.10 Arrayit Corporation
7.10.1 Arrayit Corporation Profile
7.10.2 Arrayit Corporation Main Business
7.10.3 Arrayit Corporation Chromosomal Microarray Products, Services and Solutions
7.10.4 Arrayit Corporation Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.10.5 Arrayit Corporation Recent Developments
7.11 GE Healthcare
7.11.1 GE Healthcare Profile
7.11.2 GE Healthcare Main Business
7.11.3 GE Healthcare Chromosomal Microarray Products, Services and Solutions
7.11.4 GE Healthcare Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.11.5 GE Healthcare Recent Developments
7.12 Molecular Devices LLC
7.12.1 Molecular Devices LLC Profile
7.12.2 Molecular Devices LLC Main Business
7.12.3 Molecular Devices LLC Chromosomal Microarray Products, Services and Solutions
7.12.4 Molecular Devices LLC Chromosomal Microarray Revenue (US$ Million) & (2020-2025)
7.12.5 Molecular Devices LLC Recent Developments
8 Industry Chain Analysis
8.1 Chromosomal Microarray Industrial Chain
8.2 Chromosomal Microarray Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chromosomal Microarray Sales Model
8.5.2 Sales Channel
8.5.3 Chromosomal Microarray Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Chromosomal Microarray Market Trends
Table 2. Chromosomal Microarray Market Drivers & Opportunity
Table 3. Chromosomal Microarray Market Challenges
Table 4. Chromosomal Microarray Market Restraints
Table 5. Global Chromosomal Microarray Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Chromosomal Microarray Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Chromosomal Microarray Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Chromosomal Microarray Product Type
Table 9. Key Companies Time to Begin Mass Production of Chromosomal Microarray
Table 10. Global Chromosomal Microarray Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chromosomal Microarray as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Chromosomal Microarray Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Chromosomal Microarray Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Chromosomal Microarray Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Chromosomal Microarray Sales Market Share in Value by Type (2020-2025)
Table 17. Global Chromosomal Microarray Sales Market Share in Value by Type (2026-2031)
Table 18. Global Chromosomal Microarray Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Chromosomal Microarray Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Chromosomal Microarray Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Chromosomal Microarray Sales Market Share in Value by Application (2020-2025)
Table 22. Global Chromosomal Microarray Sales Market Share in Value by Application (2026-2031)
Table 23. Global Chromosomal Microarray Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Chromosomal Microarray Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Chromosomal Microarray Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Chromosomal Microarray Sales Value by Region (2020-2025) & (%)
Table 27. Global Chromosomal Microarray Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Chromosomal Microarray Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Chromosomal Microarray Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Chromosomal Microarray Sales Value, (2026-2031) & (US$ Million)
Table 31. Thermo Fisher Scientific Inc. Basic Information List
Table 32. Thermo Fisher Scientific Inc. Description and Business Overview
Table 33. Thermo Fisher Scientific Inc. Chromosomal Microarray Products, Services and Solutions
Table 34. Revenue (US$ Million) in Chromosomal Microarray Business of Thermo Fisher Scientific Inc. (2020-2025)
Table 35. Thermo Fisher Scientific Inc. Recent Developments
Table 36. Bio-Rad Laboratories Basic Information List
Table 37. Bio-Rad Laboratories Description and Business Overview
Table 38. Bio-Rad Laboratories Chromosomal Microarray Products, Services and Solutions
Table 39. Revenue (US$ Million) in Chromosomal Microarray Business of Bio-Rad Laboratories (2020-2025)
Table 40. Bio-Rad Laboratories Recent Developments
Table 41. MedGenome Basic Information List
Table 42. MedGenome Description and Business Overview
Table 43. MedGenome Chromosomal Microarray Products, Services and Solutions
Table 44. Revenue (US$ Million) in Chromosomal Microarray Business of MedGenome (2020-2025)
Table 45. MedGenome Recent Developments
Table 46. Scott Minifab Basic Information List
Table 47. Scott Minifab Description and Business Overview
Table 48. Scott Minifab Chromosomal Microarray Products, Services and Solutions
Table 49. Revenue (US$ Million) in Chromosomal Microarray Business of Scott Minifab (2020-2025)
Table 50. Scott Minifab Recent Developments
Table 51. Agilent Technologies Inc. Basic Information List
Table 52. Agilent Technologies Inc. Description and Business Overview
Table 53. Agilent Technologies Inc. Chromosomal Microarray Products, Services and Solutions
Table 54. Revenue (US$ Million) in Chromosomal Microarray Business of Agilent Technologies Inc. (2020-2025)
Table 55. Agilent Technologies Inc. Recent Developments
Table 56. Perkin Elmer Inc. Basic Information List
Table 57. Perkin Elmer Inc. Description and Business Overview
Table 58. Perkin Elmer Inc. Chromosomal Microarray Products, Services and Solutions
Table 59. Revenue (US$ Million) in Chromosomal Microarray Business of Perkin Elmer Inc. (2020-2025)
Table 60. Perkin Elmer Inc. Recent Developments
Table 61. Illumina Inc. Basic Information List
Table 62. Illumina Inc. Description and Business Overview
Table 63. Illumina Inc. Chromosomal Microarray Products, Services and Solutions
Table 64. Revenue (US$ Million) in Chromosomal Microarray Business of Illumina Inc. (2020-2025)
Table 65. Illumina Inc. Recent Developments
Table 66. Microarrays Inc. Basic Information List
Table 67. Microarrays Inc. Description and Business Overview
Table 68. Microarrays Inc. Chromosomal Microarray Products, Services and Solutions
Table 69. Revenue (US$ Million) in Chromosomal Microarray Business of Microarrays Inc. (2020-2025)
Table 70. Microarrays Inc. Recent Developments
Table 71. Merck KGaA Basic Information List
Table 72. Merck KGaA Description and Business Overview
Table 73. Merck KGaA Chromosomal Microarray Products, Services and Solutions
Table 74. Revenue (US$ Million) in Chromosomal Microarray Business of Merck KGaA (2020-2025)
Table 75. Merck KGaA Recent Developments
Table 76. Arrayit Corporation Basic Information List
Table 77. Arrayit Corporation Description and Business Overview
Table 78. Arrayit Corporation Chromosomal Microarray Products, Services and Solutions
Table 79. Revenue (US$ Million) in Chromosomal Microarray Business of Arrayit Corporation (2020-2025)
Table 80. Arrayit Corporation Recent Developments
Table 81. GE Healthcare Basic Information List
Table 82. GE Healthcare Description and Business Overview
Table 83. GE Healthcare Chromosomal Microarray Products, Services and Solutions
Table 84. Revenue (US$ Million) in Chromosomal Microarray Business of GE Healthcare (2020-2025)
Table 85. GE Healthcare Recent Developments
Table 86. Molecular Devices LLC Basic Information List
Table 87. Molecular Devices LLC Description and Business Overview
Table 88. Molecular Devices LLC Chromosomal Microarray Products, Services and Solutions
Table 89. Revenue (US$ Million) in Chromosomal Microarray Business of Molecular Devices LLC (2020-2025)
Table 90. Molecular Devices LLC Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Chromosomal Microarray Downstream Customers
Table 94. Chromosomal Microarray Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Chromosomal Microarray Product Picture
Figure 2. Global Chromosomal Microarray Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Chromosomal Microarray Sales Value (2020-2031) & (US$ Million)
Figure 4. Chromosomal Microarray Report Years Considered
Figure 5. Global Chromosomal Microarray Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Chromosomal Microarray Revenue in 2024
Figure 7. Chromosomal Microarray Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Xon Array Picture
Figure 9. 750K Array Picture
Figure 10. Optima Array Picture
Figure 11. Others Picture
Figure 12. Global Chromosomal Microarray Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 13. Global Chromosomal Microarray Sales Value Market Share by Type, 2024 & 2031
Figure 14. Product Picture of Autism
Figure 15. Product Picture of Angelman Syndrome
Figure 16. Product Picture of Williams Syndrome
Figure 17. Product Picture of DiGeorge Syndrome
Figure 18. Product Picture of Prader-Willi Syndrome
Figure 19. Product Picture of Others
Figure 20. Global Chromosomal Microarray Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Chromosomal Microarray Sales Value Market Share by Application, 2024 & 2031
Figure 22. North America Chromosomal Microarray Sales Value (2020-2031) & (US$ Million)
Figure 23. North America Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
Figure 24. Europe Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 25. Europe Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
Figure 26. Asia Pacific Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 27. Asia Pacific Chromosomal Microarray Sales Value by Region (%), 2024 VS 2031
Figure 28. South America Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 29. South America Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
Figure 30. Middle East & Africa Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 31. Middle East & Africa Chromosomal Microarray Sales Value by Country (%), 2024 VS 2031
Figure 32. Key Countries/Regions Chromosomal Microarray Sales Value (%), (2020-2031)
Figure 33. United States Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 34. United States Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
Figure 35. United States Chromosomal Microarray Sales Value by Application (%), 2024 VS 2031
Figure 36. Europe Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 37. Europe Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
Figure 38. Europe Chromosomal Microarray Sales Value by Application (%), 2024 VS 2031
Figure 39. China Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 40. China Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
Figure 41. China Chromosomal Microarray Sales Value by Application (%), 2024 VS 2031
Figure 42. Japan Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 43. Japan Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
Figure 44. Japan Chromosomal Microarray Sales Value by Application (%), 2024 VS 2031
Figure 45. South Korea Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 46. South Korea Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
Figure 47. South Korea Chromosomal Microarray Sales Value by Application (%), 2024 VS 2031
Figure 48. Southeast Asia Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
Figure 50. Southeast Asia Chromosomal Microarray Sales Value by Application (%), 2024 VS 2031
Figure 51. India Chromosomal Microarray Sales Value, (2020-2031) & (US$ Million)
Figure 52. India Chromosomal Microarray Sales Value by Type (%), 2024 VS 2031
Figure 53. India Chromosomal Microarray Sales Value by Application (%), 2024 VS 2031
Figure 54. Chromosomal Microarray Industrial Chain
Figure 55. Chromosomal Microarray Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Chromosomal Microarray in 2031?
The global market size of Chromosomal Microarray in 2031 was 3149 Million USD.
What was the global market size of Chromosomal Microarray in 2025?
Which companies rank high in the global Chromosomal Microarray market?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Chromosomal Microarray market size from 2025 to 2031?
Related Reports
Chromosomal Microarray - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chromosomal Microarray was estimated to be worth US$ 1898 million in 2025 and is projected to reach US$ 3398 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 119
USD 3950.00
(Single User License)
Global Chromosomal Microarray Market Research Report 2026
The global Chromosomal Microarray market was valued at US$ 1898 million in 2025 and is anticipated to reach US$ 3398 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 113
USD 2900.00
(Single User License)
Global Chromosomal Microarray Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chromosomal Microarray market size was US$ 1759 million in 2024 and is forecast to a readjusted size of US$ 3149 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 100
USD 4250.00
(Single User License)
Global Chromosomal Microarray Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chromosomal Microarray market is projected to grow from US$ 1759 million in 2024 to US$ 3149 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 140
USD 4900.00
(Single User License)
Global Chromosomal Microarray Market Research Report 2025
The global market for Chromosomal Microarray was valued at US$ 1759 million in the year 2024 and is projected to reach a revised size of US$ 3149 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Chromosomal Microarray Market Insights, Forecast to 2030
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published Date: 2024-04-12
Pages: 106
USD 4900.00
(Single User License)
Global Chromosomal Microarray Market Research Report 2024
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published Date: 2024-01-17
Pages: 86
USD 2900.00
(Single User License)
Chromosomal Microarray - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published Date: 2024-01-10
Pages: 105
USD 3950.00
(Single User License)
Chromosomal Microarray - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chromosomal Microarray was estimated to be worth US$ 1898 million in 2025 and is projected to reach US$ 3398 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 119
USD 3950.00 (Single User License)Global Chromosomal Microarray Market Research Report 2026
The global Chromosomal Microarray market was valued at US$ 1898 million in 2025 and is anticipated to reach US$ 3398 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-04-17
Pages: 113
USD 2900.00 (Single User License)Global Chromosomal Microarray Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chromosomal Microarray market size was US$ 1759 million in 2024 and is forecast to a readjusted size of US$ 3149 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 100
USD 4250.00 (Single User License)Global Chromosomal Microarray Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chromosomal Microarray market is projected to grow from US$ 1759 million in 2024 to US$ 3149 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 140
USD 4900.00 (Single User License)Global Chromosomal Microarray Market Research Report 2025
The global market for Chromosomal Microarray was valued at US$ 1759 million in the year 2024 and is projected to reach a revised size of US$ 3149 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)Global Chromosomal Microarray Market Insights, Forecast to 2030
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published: 2024-04-12
Pages: 106
USD 4900.00 (Single User License)Global Chromosomal Microarray Market Research Report 2024
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published: 2024-01-17
Pages: 86
USD 2900.00 (Single User License)Chromosomal Microarray - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published: 2024-01-10
Pages: 105
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now